Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC
Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
Prediction for pCR After Neoadjuvant Immunotherapy Combined With Chemotherapy Using
Single-Cell RNA Sequencing in Patients With Locally Advanced Esophageal Squamous Cell
Carcinoma